Kentucky bill lets patients try experimental drugs, limits lawsuits

AN ACT relating to the use of experimental treatments for life-threatening or severely debilitating illness.

Introduced· 2026-02-03

Who's it for

Who's it for: Manufacturers

What it means for you

5/10Mixed

Mixed: some good, some bad ·

Right removedCost shiftImmunity

Plain‑English summary, cross‑checked against the official bill text.

If passed, Kentucky would let patients get experimental treatments but could force them to pay and stop them from suing manufacturers.

Our take

What we think, in plain words.

The bill could give sick people a new hope, yet it may leave them with huge bills and no legal recourse if things go wrong, so voters should watch it closely.

Take action

Add your name. At 100 signatures we compile this petition and deliver it to the office — and every signer gets a message to send their own representatives.

0 of 100 in‑district signatures

Step 1 · Pick your position

Step 2 · Add your name

Picking a side above doesn't sign anything yet — a free account records your name on the petition and keeps it one signature per person. We'll bring you straight back here with your choice saved.

The facts

What the bill actually says, no spin.

Creates definitions for eligible patients and facilities.
Lets manufacturers give individualized investigational drugs, biologics, or devices.
Manufacturers may require patients to cover the costs.
Heirs of a patient who dies are not liable for those costs.
Licensing boards cannot discipline providers for recommending such treatments.
Blocks private lawsuits against manufacturers that acted with reasonable care.
Does not require insurance to cover or hospitals to provide the treatments.